HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 13.86
+0.32 (2.36%)
Sep 30, 2026, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 11.44 billion as of September 29, 2026. Its market cap has decreased by -6.10% in one year.
Market Cap
11.44B
Enterprise Value
9.33B
Revenue
1.40B
Ranking
n/a
PE Ratio
17.25
Stock Price
13.86
ChartMarket Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 11.44B, an increase of 35.22%. That is a compound annual growth rate of 5.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 11.44B | 12.56% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 17.60B |
| Ascentage Pharma Group International | 10.84B |
| GenFleet Therapeutics (Shanghai) | 10.15B |
| Everest Medicines | 9.97B |
| Nanjing Leads Biolabs | 9.75B |
| Ascletis Pharma | 9.03B |
| Suzhou Ribo Life Science | 8.72B |
| CStone Pharmaceuticals | 8.19B |